News of Note—ViewRay to trial MRIdian system in inoperable pancreatic cancer, and more

News of note

> ViewRay launched a prospective clinical trial for its MRI-guided radiation therapy system in locally advanced unresectable pancreatic cancer. Release | Read more about ViewRay

> Boston Scientific is rolling out its suite of MRI-conditional Resonate implantable cardioverter defibrillators. Release

> Novocure announced data from a phase 3 study showing that patients with newly diagnosed glioblastoma who underwent a combination treatment of its Optune device and the chemo drug temozolomide fared better than those who received temozolomide alone. Release

FREE DAILY NEWSLETTER

Like this story? Subscribe to FierceBiotech!

Biopharma is a fast-growing world where big ideas come along every day. Our subscribers rely on FierceBiotech as their must-read source for the latest news, analysis and data in the world of biotech and pharma R&D. Sign up today to get biotech news and updates delivered to your inbox and read on the go.

Suggested Articles

Janssen is planning its first completely virtual clinical trial, using personal smartphones and wearable devices with no in-person site visits.

Sensyne Health aims to bring its AI tools to America, and it’s enlisting IT giant Cognizant and data infrastructure specialist Agorai to help.

Daré Bioscience added a microchip-based implant to its pipeline and reported data from a pre-pivotal study of a hormone-free contraceptive ring.